ES2103181A1 - Amidas naftalenicas con accion antagonista de los leucotrienos. - Google Patents

Amidas naftalenicas con accion antagonista de los leucotrienos.

Info

Publication number
ES2103181A1
ES2103181A1 ES09401696A ES9401696A ES2103181A1 ES 2103181 A1 ES2103181 A1 ES 2103181A1 ES 09401696 A ES09401696 A ES 09401696A ES 9401696 A ES9401696 A ES 9401696A ES 2103181 A1 ES2103181 A1 ES 2103181A1
Authority
ES
Spain
Prior art keywords
hydrogen
bound
naphthalene
leukotriene
antagonistic action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09401696A
Other languages
English (en)
Other versions
ES2103181B1 (es
Inventor
Casellas David Mauleon
Germano Carganico
Torro M Desamparados Fos
Perez Luisa Garcia
Benet Albert Palomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES09401696A priority Critical patent/ES2103181B1/es
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to EP95929014A priority patent/EP0775133B1/en
Priority to AU32539/95A priority patent/AU3253995A/en
Priority to DE69521132T priority patent/DE69521132T2/de
Priority to PT95929014T priority patent/PT775133E/pt
Priority to ES95929014T priority patent/ES2156944T3/es
Priority to PCT/EP1995/002970 priority patent/WO1996004267A1/en
Priority to DK95929014T priority patent/DK0775133T3/da
Priority to AT95929014T priority patent/ATE201678T1/de
Publication of ES2103181A1 publication Critical patent/ES2103181A1/es
Application granted granted Critical
Publication of ES2103181B1 publication Critical patent/ES2103181B1/es
Priority to GR20010401313T priority patent/GR3036462T3/el
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

AMIDAS NAFTALENICAS CON ACCION ANTAGONISTA DE LOS LEUCOTRIENOS. LA PRESENTE INVENCION SE REFIERE A NUEVAS AMIDAS NAFTALENICAS DE FORMULA I, FORMULA DONDE EL SUSTITUYENTE QUE CONTIENE A A ESTA UNIDO A LA POSICION 6 O 7 DEL SISTEMA 2-NAFTOLICO; R1 ES HIDROGENO O METILO; R2 ES HIDROGENO, FLUOR, CLORO O -OCH3; R3 ES HIDROGENO, FLUOR, CLORO O BROMO; -A- ES -CO-NR4- O -NR4-CO-; R4 ES HIDROGENO O METILO; B ES 5-TETRAZOLILO O -COOR5, R5 ES HIDROGENO, (C1-C4)-ALQUILO O FENILALQUILO; M ES 0 O 1; N Y P SON ENTEROS COMPRENDIDOS ENTRE 0 Y 6, CON LA CONDICION DE QUE N+P SEA MENOR O IGUAL A 6. DICHOS COMPUESTOS PRESENTAN UNA ACCION ANTAGONISTA DE LOS LEUCOTRIENOS, PUDIENDO SER UTILIZADOS COMO ANTIINFLAMATORIOS, ANTIALERGICOS O EN EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA CARDIOVASCULAR.
ES09401696A 1994-01-31 1994-08-01 Amidas naftalenicas con accion antagonista de los leucotrienos. Expired - Lifetime ES2103181B1 (es)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ES09401696A ES2103181B1 (es) 1994-08-01 1994-08-01 Amidas naftalenicas con accion antagonista de los leucotrienos.
AT95929014T ATE201678T1 (de) 1994-08-01 1995-07-27 Naphthalenamide als leukotrien antagonisten
DE69521132T DE69521132T2 (de) 1994-08-01 1995-07-27 Naphthalenamide als leukotrien antagonisten
PT95929014T PT775133E (pt) 1994-08-01 1995-07-27 Amidas de naftaleno com accao antagonista do leucotrieno
ES95929014T ES2156944T3 (es) 1994-08-01 1995-07-27 Amidas naftalenicas con accion antagonista de los leucotrienos.
PCT/EP1995/002970 WO1996004267A1 (en) 1994-08-01 1995-07-27 Naphthalene amides having leukotriene-antagonistic action
EP95929014A EP0775133B1 (en) 1994-08-01 1995-07-27 Naphthalene amides having leukotriene-antagonistic action
AU32539/95A AU3253995A (en) 1994-08-01 1995-07-27 Naphthalene amides having leukotriene-antagonistic action
DK95929014T DK0775133T3 (da) 1994-01-31 1995-07-27 Naphthlenamider med leukotrien-antagonistisk virkning
GR20010401313T GR3036462T3 (en) 1994-08-01 2001-08-29 Naphthalene amides having leukotriene-antagonistic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09401696A ES2103181B1 (es) 1994-08-01 1994-08-01 Amidas naftalenicas con accion antagonista de los leucotrienos.

Publications (2)

Publication Number Publication Date
ES2103181A1 true ES2103181A1 (es) 1997-08-16
ES2103181B1 ES2103181B1 (es) 1998-04-01

Family

ID=8287122

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09401696A Expired - Lifetime ES2103181B1 (es) 1994-01-31 1994-08-01 Amidas naftalenicas con accion antagonista de los leucotrienos.
ES95929014T Expired - Lifetime ES2156944T3 (es) 1994-08-01 1995-07-27 Amidas naftalenicas con accion antagonista de los leucotrienos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95929014T Expired - Lifetime ES2156944T3 (es) 1994-08-01 1995-07-27 Amidas naftalenicas con accion antagonista de los leucotrienos.

Country Status (8)

Country Link
EP (1) EP0775133B1 (es)
AT (1) ATE201678T1 (es)
AU (1) AU3253995A (es)
DE (1) DE69521132T2 (es)
ES (2) ES2103181B1 (es)
GR (1) GR3036462T3 (es)
PT (1) PT775133E (es)
WO (1) WO1996004267A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150848A1 (es) * 1998-04-15 2000-12-01 Menarini Lab Heterociclos metiloxinaftil sustituidos con accion antagonista de los leucotrienos.

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117551B1 (es) * 1995-12-29 1999-04-01 Menarini Lab Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas.
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
DE60126143T2 (de) * 2000-12-06 2007-11-15 Sanofi-Aventis Deutschland Gmbh Guanidin- und amidin-verbindungen, und ihre verwendung als faktor xa-inhibitoren
TWI312779B (es) 2000-12-28 2009-08-01 Daiichi Seiyaku Co
TW591020B (en) * 2001-06-20 2004-06-11 Wyeth Corp 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
GB2405146A (en) * 2002-06-07 2005-02-23 Cortical Pty Ltd Napthalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
MXPA06000850A (es) 2003-07-24 2006-03-30 Daiichi Seiyaku Co Compuesto de acido ciclohexancarboxilico.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579866A (en) * 1984-05-29 1986-04-01 Usv Pharmaceutical Corp. Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents
EP0315399A2 (en) * 1987-11-03 1989-05-10 Rhone-Poulenc Rorer International (Holdings) Inc. Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same
EP0348155A1 (en) * 1988-06-21 1989-12-27 Rhone-Poulenc Rorer International (Holdings) Inc. Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579866A (en) * 1984-05-29 1986-04-01 Usv Pharmaceutical Corp. Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents
EP0315399A2 (en) * 1987-11-03 1989-05-10 Rhone-Poulenc Rorer International (Holdings) Inc. Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same
EP0348155A1 (en) * 1988-06-21 1989-12-27 Rhone-Poulenc Rorer International (Holdings) Inc. Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150848A1 (es) * 1998-04-15 2000-12-01 Menarini Lab Heterociclos metiloxinaftil sustituidos con accion antagonista de los leucotrienos.

Also Published As

Publication number Publication date
DE69521132D1 (de) 2001-07-05
ATE201678T1 (de) 2001-06-15
EP0775133B1 (en) 2001-05-30
ES2156944T3 (es) 2001-08-01
WO1996004267A1 (en) 1996-02-15
GR3036462T3 (en) 2001-11-30
AU3253995A (en) 1996-03-04
DE69521132T2 (de) 2001-09-27
PT775133E (pt) 2001-10-30
ES2103181B1 (es) 1998-04-01
EP0775133A1 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
CA2217771A1 (en) O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
MY110821A (en) Oxidation inhibited arylcyclobutene polymers
AU4640899A (en) Crosslinkable liquid crystalline compounds
YU82304A (sh) Kristalni 3,4,4-trisupstituisani-piperidinil-n-alkilkarboksilati, intermedijeri i postupak za dobijanje
HUP9903965A2 (hu) Helyettesített 6,5-heterobiciklusos származékok
AU2002327747A1 (en) Substituted pentacene semiconductors
MY131297A (en) Herbicides
HUP9901244A2 (hu) Kannabinoid receptor affinitással rendelkező 3-pirazolkarboxamid-származékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
GR3036462T3 (en) Naphthalene amides having leukotriene-antagonistic action
PL319104A1 (en) 2,3-dihydro-1-(2,2,2-trifluoroethly0)-2-oxo-5-phenyl-1h-1,4-benzodiazepinmes
GB9817272D0 (en) Liquid crystalline compounds
KR100353264B1 (es)
TW337985B (en) "N-(B-branched alkyl)-1, 2-benzisothiolin, 3ones, their preparation and their use as industrial biocides"
ID22156A (id) Turunan substitusi benzosikloheptapiridina yang berguna untuk menghambat fernesil protein transferase
ATE223226T1 (de) Azazyklohexapeptid-verbindungen
ES2103180A1 (es) Fenilacetamidas con accion antagonista de los leucotrienos.
EP0721945A4 (en) BENZOLACTAM DERIVATIVES
EP0663392A4 (en) BENZOLSULPHONAMIDE DERIVATIVE AND ITS USE.
FI951588A0 (fi) Öljykoostumuksia
AU1399092A (en) Benzothiazole derivative
AU2402892A (en) 5-aminosulfonanilide compounds
ES2117551A1 (es) Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas.
ES8103077A1 (es) Procedimiento de preparacion de nuevos derivados fenotiazi- nos o de sus sales de adicion acidas
ES8308819A1 (es) Productos halogenados.
HK1033937A1 (en) Novel antiarrhythmic compounds.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970816

Kind code of ref document: A1

Effective date: 19970816